Quick Summary

Holy Basil (Ocimum tenuiflorum) is a traditional medicinal herb with a history of use for various health concerns. Investigated properties include stress reduction, cognitive function support, antimicrobial effects, and potential roles in managing metabolic syndrome and oral health. Clinical trials suggest it may help reduce both subjective and objective stress markers and improve sleep quality. Preclinical and limited clinical studies indicate possible anticancer, anti-inflammatory, and cognitive-supportive effects. However, much of the evidence remains preliminary, emphasizing the need for further well-designed clinical research.

What Is It?

Holy Basil, also known as Tulsi, is a plant native to the Indian subcontinent, valued in traditional medicine systems such as Ayurveda. It belongs to the genus Ocimum and is recognized for its aromatic properties and use in herbal remedies.

Traditional Uses

  • Stress relief and mood support
  • Improvement of cognitive function
  • Management of metabolic conditions like diabetes and metabolic syndrome
  • Oral health maintenance through antimicrobial activity
  • Support for inflammatory conditions

Active Compounds

Holy Basil contains a range of bioactive compounds including polyphenols, terpenes, terpenoids, flavonoids, and essential oils. These constituents contribute to its antioxidant, anti-inflammatory, antimicrobial, and adaptogenic properties.

Potential Benefits with Evidence Levels

  • Stress reduction and sleep quality (Human clinical trials – RCTs): An 8-week randomized, double-blind placebo-controlled trial with 100 adults experiencing stress found that supplementation with standardized holy basil extract (Holixer™) improved perceived stress scale scores, reduced hair cortisol levels, and enhanced subjective sleep quality (PMID: 36185698).
  • Cognitive function (Limited human clinical trials and preclinical evidence): One clinical trial reported improved reaction times in an executive function task, with other cognitive benefits unconfirmed and requiring further study. Preclinical data support neuroprotective and nootropic effects (PMID: 41575193).
  • Antimicrobial and oral health (Systematic reviews and meta-analyses): Ayurvedic and herbal plaque control agents including Ocimum species have shown promise in reducing dental plaque, gingivitis, and oral bacterial counts versus placebo or standard care, supporting safe adjunctive use in oral hygiene (PMID: 38144032, PMID: 36011693, PMID: 40292252, PMID: 40364419).
  • Anti-inflammatory and related effects (Preclinical and limited clinical evidence): Holy Basil demonstrates anti-inflammatory and antioxidant activities which may underpin adaptogenic effects and modulation of chronic lifestyle-related conditions; however, human data remain limited (PMID: 41901106).
  • Anticancer potential (Preclinical and limited human data): In vitro and in vivo studies suggest anticancer properties such as cytotoxicity, apoptosis induction, and inhibition of tumor progression. Clinical evidence in humans is currently limited (PMID: 35625980).
  • Metabolic syndrome and glycemic control (Limited clinical and preclinical evidence): Traditionally used for metabolic syndrome and type 2 diabetes, preclinical research supports antihyperglycemic effects. Clinical confirmation in humans is still needed.

Side Effects

Holy Basil has been well tolerated in clinical trials with no major adverse effects reported. Mild and transient gastrointestinal symptoms have occasionally been noted. No significant safety concerns have emerged from available studies (PMID: 36185698, PMID: 41236933).

Drug Interactions

There is insufficient specific clinical evidence regarding drug interactions with Holy Basil. Caution is advised, particularly when combined with conventional medications, until more information is available.

Who Should Avoid It

  • Individuals with known allergies or sensitivities to basil or related plants.
  • Pregnant or breastfeeding women should avoid use unless under advice from a healthcare professional due to lack of sufficient safety data.

Evidence Limitations

  • Many studies have small sample sizes, variable methodologies, and short treatment durations.
  • Several findings are derived from preclinical or in vitro studies and require confirmation by rigorous human clinical trials.
  • Variation in herbal preparations, dosages, and outcome measures complicates result interpretation.
  • Limited long-term safety data and insufficient information on drug interactions and use in special populations.
  • Well-designed large-scale placebo-controlled clinical trials are needed to substantiate efficacy and safety claims.

References

Last Reviewed

June 2024

Disclaimer: This page provides information based on current scientific evidence and is intended for educational purposes only. It does not constitute medical advice. Please consult a healthcare professional before starting any new supplement or treatment, especially if you have existing health conditions or are taking medications.